{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T21:17:05Z","timestamp":1777497425004,"version":"3.51.4"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T00:00:00Z","timestamp":1775779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T00:00:00Z","timestamp":1775779200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1007\/s12282-026-01857-0","type":"journal-article","created":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T07:12:10Z","timestamp":1775805130000},"page":"770-783","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Targeting breast cancer senescence in 3D models of bone metastasis"],"prefix":"10.1007","volume":"33","author":[{"given":"Eleane C. B.","family":"Hamburger","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mansoureh Mohseni","family":"Garakani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saber","family":"Ghazizadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saleh","family":"Alfaisali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean A.","family":"Ouellet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael H.","family":"Weber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Livia","family":"Garzia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisbet","family":"Haglund","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6593-8177","authenticated-orcid":false,"given":"Derek H.","family":"Rosenzweig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,4,10]]},"reference":[{"issue":"Suppl 2","key":"1857_CR1","doi-asserted-by":"publisher","first-page":"pS202","DOI":"10.1007\/s00586-003-0609-9","volume":"12","author":"M Aebi","year":"2003","unstructured":"Aebi M. Spinal metastasis in the elderly. Eur Spine J. 2003;12(Suppl 2):pS202\u201313.","journal-title":"Eur Spine J"},{"key":"1857_CR2","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.jocn.2016.05.023","volume":"34","author":"N Batista","year":"2016","unstructured":"Batista N, et al. Emerging and established clinical, histopathological and molecular parametric prognostic factors for metastatic spine disease secondary to lung cancer: Helping surgeons make decisions. J Clin Neurosci. 2016;34:15\u201322.","journal-title":"J Clin Neurosci"},{"issue":"5","key":"1857_CR3","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1177\/2192568217710911","volume":"7","author":"MJ Clarke","year":"2017","unstructured":"Clarke MJ, et al. Systematic Review of the Outcomes of Surgical Treatment of Prostate Metastases to the Spine. Global Spine J. 2017;7(5):460\u20138.","journal-title":"Global Spine J"},{"issue":"5","key":"1857_CR4","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1055\/s-0035-1564807","volume":"6","author":"DM Sciubba","year":"2016","unstructured":"Sciubba DM, et al. A Systematic Review of Clinical Outcomes and Prognostic Factors for Patients Undergoing Surgery for Spinal Metastases Secondary to Breast Cancer. Global Spine J. 2016;6(5):482\u201396.","journal-title":"Global Spine J"},{"key":"1857_CR5","doi-asserted-by":"publisher","DOI":"10.21037\/atm.2019.04.41","author":"P Ahangar","year":"2019","unstructured":"Ahangar P, et al. Advances in personalized treatment of metastatic spine disease. Annals of Translational Medicine. 2019. https:\/\/doi.org\/10.21037\/atm.2019.04.41.","journal-title":"Annals of Translational Medicine"},{"issue":"15","key":"1857_CR6","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1001\/jama.1994.03520150074040","volume":"272","author":"AD Aaron","year":"1994","unstructured":"Aaron AD. The management of cancer metastatic to bone. JAMA. 1994;272(15):1206\u20139.","journal-title":"JAMA"},{"issue":"24","key":"1857_CR7","doi-asserted-by":"publisher","first-page":"2849","DOI":"10.1097\/01.brs.0000245838.37817.40","volume":"31","author":"A Falicov","year":"2006","unstructured":"Falicov A, et al. Impact of surgical intervention on quality of life in patients with spinal metastases. Spine (Phila Pa 1976). 2006;31(24):2849\u201356.","journal-title":"Spine (Phila Pa 1976)"},{"issue":"5","key":"1857_CR8","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1097\/01.BRS.0000048646.26222.FA","volume":"28","author":"EK Wai","year":"2003","unstructured":"Wai EK, et al. Quality of life in surgical treatment of metastatic spine disease. Spine (Phila Pa 1976). 2003;28(5):508\u201312.","journal-title":"Spine (Phila Pa 1976)"},{"key":"1857_CR9","doi-asserted-by":"crossref","unstructured":"Adler D, Pepke W, Akbar M. Operative treatment of metastatic breast cancer in the spine with regard to molecular phenotypes. Journal of Cancer Metastasis and Treatment, 2019. 2019.","DOI":"10.20517\/2394-4722.2019.03"},{"issue":"3","key":"1857_CR10","doi-asserted-by":"publisher","first-page":"365","DOI":"10.3109\/17453674.2011.566142","volume":"82","author":"O Zaikova","year":"2011","unstructured":"Zaikova O, et al. Radiotherapy or surgery for spine metastases? Acta Orthop. 2011;82(3):365\u201371.","journal-title":"Acta Orthop"},{"key":"1857_CR11","first-page":"494381","volume":"2011","author":"PS Rose","year":"2011","unstructured":"Rose PS, Clarke MJ, Dekutoski MB. Minimally invasive treatment of spinal metastases: techniques. Int J Surg Oncol. 2011;2011:494381.","journal-title":"Int J Surg Oncol"},{"key":"1857_CR12","volume-title":"Spinal Metastasis, in StatPearls","author":"E Ziu","year":"2020","unstructured":"Ziu E, Viswanathan VK, Mesfin FB. Spinal Metastasis, in StatPearls. Treasure Island (FL); 2020."},{"key":"1857_CR13","doi-asserted-by":"publisher","DOI":"10.1093\/jncics\/pkac052","author":"JE Bower","year":"2022","unstructured":"Bower JE, et al. Acute and Chronic Effects of Adjuvant Therapy on Inflammatory Markers in Breast Cancer Patients. JNCI Cancer Spectrum. 2022. https:\/\/doi.org\/10.1093\/jncics\/pkac052.","journal-title":"JNCI Cancer Spectrum"},{"issue":"8","key":"1857_CR14","doi-asserted-by":"publisher","first-page":"180","DOI":"10.5306\/wjco.v9.i8.180","volume":"9","author":"S Qin","year":"2018","unstructured":"Qin S, Schulte BA, Wang GY. Role of senescence induction in cancer treatment. World J Clin Oncol. 2018;9(8):180\u20137.","journal-title":"World J Clin Oncol"},{"key":"1857_CR15","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.semcancer.2019.06.018","volume":"62","author":"E Mavrogonatou","year":"2020","unstructured":"Mavrogonatou E, Pratsinis H, Kletsas D. The role of senescence in cancer development. Semin Cancer Biol. 2020;62:182\u201391.","journal-title":"Semin Cancer Biol"},{"key":"1857_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2021.111708","volume":"139","author":"PS Rawat","year":"2021","unstructured":"Rawat PS, et al. Doxorubicin-induced cardiotoxicity: An update on the molecular mechanism and novel therapeutic strategies for effective management. Biomedicine & Pharmacotherapy. 2021;139:111708.","journal-title":"Biomedicine & Pharmacotherapy"},{"issue":"7","key":"1857_CR17","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.3390\/biology12071031","volume":"12","author":"AI Afonso","year":"2023","unstructured":"Afonso AI, et al. Doxorubicin Dose-Dependent Impact on Physiological Balance\u2014A Holistic Approach in a Rat Model. Biology. 2023;12(7):1031.","journal-title":"Biology"},{"key":"1857_CR18","doi-asserted-by":"publisher","DOI":"10.3390\/ma11091485","author":"P Ahangar","year":"2018","unstructured":"Ahangar P, et al. Nanoporous 3D-Printed Scaffolds for Local Doxorubicin Delivery in Bone Metastases Secondary to Prostate Cancer. Materials. 2018. https:\/\/doi.org\/10.3390\/ma11091485.","journal-title":"Materials"},{"key":"1857_CR19","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.54693","author":"H Cherif","year":"2020","unstructured":"Cherif H, et al. Senotherapeutic drugs for human intervertebral disc degeneration and low back pain. Elife. 2020. https:\/\/doi.org\/10.7554\/eLife.54693.","journal-title":"Elife"},{"issue":"7","key":"1857_CR20","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15071927","volume":"15","author":"M Ye","year":"2023","unstructured":"Ye M, et al. Senescent Stromal Cells in the Tumor Microenvironment: Victims or Accomplices? Cancers. 2023;15(7):1927.","journal-title":"Cancers"},{"key":"1857_CR21","doi-asserted-by":"crossref","unstructured":"Kim KM, Noh JH, Gorospe M. Senolysis and Senostasis Through the Plasma Membrane, in Senolytics in Disease, Ageing and Longevity, D. Mu\u00f1oz-Espin and M. Demaria, Editors. 2020, Springer International Publishing: Cham. pp. 131\u2013143.","DOI":"10.1007\/978-3-030-44903-2_7"},{"issue":"8","key":"1857_CR22","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.3390\/biom13081257","volume":"13","author":"M Mannarino","year":"2023","unstructured":"Mannarino M, et al. Senolytic Combination Treatment Is More Potent Than Single Drugs in Reducing Inflammatory and Senescence Burden in Cells from Painful Degenerating IVDs. Biomolecules. 2023;13(8):1257.","journal-title":"Biomolecules"},{"key":"1857_CR23","doi-asserted-by":"publisher","first-page":"e54693","DOI":"10.7554\/eLife.54693","volume":"9","author":"H Cherif","year":"2020","unstructured":"Cherif H, et al. Senotherapeutic drugs for human intervertebral disc degeneration and low back pain. eLife. 2020;9:e54693.","journal-title":"eLife"},{"issue":"3","key":"1857_CR24","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1007\/s43440-020-00099-x","volume":"72","author":"S Nasr","year":"2020","unstructured":"Nasr S, Varshosaz J, Hajhashemi V. Ortho-vanillin nanoparticle-doped glucan microspheres exacerbate the anti-arthritic effects of methotrexate in adjuvant-induced arthritis in rats. Pharmacol Rep. 2020;72(3):680\u201391.","journal-title":"Pharmacol Rep"},{"key":"1857_CR25","doi-asserted-by":"crossref","unstructured":"Lu\u00eds C et al. Nutritional senolytics and senomorphics: Implications to immune cells metabolism and aging \u2013 from theory to practice. Front Nutr, 2022. 9:958563.","DOI":"10.3389\/fnut.2022.958563"},{"issue":"4","key":"1857_CR26","doi-asserted-by":"publisher","first-page":"485","DOI":"10.3390\/pharmaceutics16040485","volume":"16","author":"H-M Yun","year":"2024","unstructured":"Yun H-M, et al. Vanillin Promotes Osteoblast Differentiation, Mineral Apposition, and Antioxidant Effects in Pre-Osteoblasts. Pharmaceutics. 2024;16(4):485.","journal-title":"Pharmaceutics"},{"issue":"5","key":"1857_CR27","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1021\/ml4000657","volume":"4","author":"B Vu","year":"2013","unstructured":"Vu B, et al. Discovery of RG7112: A Small-Molecule MDM2 Inhibitor in Clinical Development. ACS Med Chem Lett. 2013;4(5):466\u20139.","journal-title":"ACS Med Chem Lett"},{"issue":"11","key":"1857_CR28","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1016\/S1470-2045(12)70474-6","volume":"13","author":"I Ray-Coquard","year":"2012","unstructured":"Ray-Coquard I, et al. Effect of the MDM2 antagonist RG7112 on the P53 pathway in patients with MDM2-amplified, well-differentiated or dedifferentiated liposarcoma: an exploratory proof-of-mechanism study. Lancet Oncol. 2012;13(11):1133\u201340.","journal-title":"Lancet Oncol"},{"issue":"4","key":"1857_CR29","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1158\/1078-0432.CCR-15-0481","volume":"22","author":"M Andreeff","year":"2016","unstructured":"Andreeff M, et al. Results of the Phase I Trial of RG7112, a Small-Molecule MDM2 Antagonist in Leukemia. Clin Cancer Res. 2016;22(4):868\u201376.","journal-title":"Clin Cancer Res"},{"issue":"22","key":"1857_CR30","doi-asserted-by":"publisher","first-page":"3589","DOI":"10.3390\/cells11223589","volume":"11","author":"L Li","year":"2022","unstructured":"Li L, et al. o-Vanillin Modulates Cell Phenotype and Extracellular Vesicles of Human Mesenchymal Stem Cells and Intervertebral Disc Cells. Cells. 2022;11(22):3589.","journal-title":"Cells"},{"issue":"1","key":"1857_CR31","doi-asserted-by":"publisher","first-page":"9734816","DOI":"10.1155\/2016\/9734816","volume":"2016","author":"DP Bezerra","year":"2016","unstructured":"Bezerra DP, Soares AK, de Sousa DP. Overview of the role of vanillin on redox status and cancer development. Oxidative medicine and cellular longevity. 2016;2016(1):9734816.","journal-title":"Oxidative medicine and cellular longevity"},{"key":"1857_CR32","unstructured":"Park H et al. Continuous two-phase\u2009<\u2009em\u2009>\u2009in vitro\u2009co-culture model of the enthesis. bioRxiv, 2022: p. 2022.02.07.479445."},{"key":"1857_CR33","doi-asserted-by":"publisher","first-page":"3617","DOI":"10.12659\/MSM.914295","volume":"25","author":"X Hu","year":"2019","unstructured":"Hu X, Zhang H. Doxorubicin-induced cancer cell senescence shows a time delay effect and is inhibited by epithelial-mesenchymal transition (EMT). Med Sci Monit. 2019;25:3617\u201323.","journal-title":"Med Sci Monit"},{"issue":"3","key":"1857_CR34","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1007\/s11357-023-00728-2","volume":"45","author":"Y Gao","year":"2023","unstructured":"Gao Y, et al. Increased cellular senescence in doxorubicin-induced murine ovarian injury: effect of senolytics. GeroScience. 2023;45(3):1775\u201390.","journal-title":"GeroScience"},{"key":"1857_CR35","doi-asserted-by":"publisher","first-page":"111689","DOI":"10.1016\/j.mad.2022.111689","volume":"206","author":"E Bientinesi","year":"2022","unstructured":"Bientinesi E, et al. Doxorubicin-induced senescence in normal fibroblasts promotes in vitro tumour cell growth and invasiveness: The role of Quercetin in modulating these processes. Mech Ageing Dev. 2022;206:111689.","journal-title":"Mech Ageing Dev"},{"issue":"1","key":"1857_CR36","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41514-024-00135-7","volume":"10","author":"AN Linders","year":"2024","unstructured":"Linders AN, et al. A review of the pathophysiological mechanisms of doxorubicin-induced cardiotoxicity and aging. npj Aging. 2024;10(1):9.","journal-title":"npj Aging"},{"issue":"7","key":"1857_CR37","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.3390\/cells11071106","volume":"11","author":"V Kirsch","year":"2022","unstructured":"Kirsch V, et al. In Vitro Characterization of Doxorubicin-Mediated Stress-Induced Premature Senescence in Human Chondrocytes. Cells. 2022;11(7):1106.","journal-title":"Cells"},{"issue":"5","key":"1857_CR38","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1158\/0008-5472.CAN-19-2348","volume":"80","author":"Z Yao","year":"2020","unstructured":"Yao Z, et al. Therapy-Induced Senescence Drives Bone Loss. Cancer Res. 2020;80(5):1171\u201382.","journal-title":"Cancer Res"},{"issue":"4","key":"1857_CR39","doi-asserted-by":"publisher","first-page":"902","DOI":"10.37349\/etat.2024.00254","volume":"5","author":"SN Chembukavu","year":"2024","unstructured":"Chembukavu SN, Lindsay AJ. Therapy-induced senescence in breast cancer: an overview. Explor Target Antitumor Ther. 2024;5(4):902\u201320.","journal-title":"Explor Target Antitumor Ther"},{"issue":"15","key":"1857_CR40","doi-asserted-by":"publisher","DOI":"10.3390\/cells13151281","volume":"13","author":"Y Liu","year":"2024","unstructured":"Liu Y, Lomeli I, Kron SJ. Therapy-induced cellular senescence: potentiating tumor elimination or driving cancer resistance and recurrence? Cells. 2024;13(15):1281.","journal-title":"Cells"},{"key":"1857_CR41","doi-asserted-by":"crossref","unstructured":"Hofbauer LC, Baschant U, Hofbauer C. Targeting senescent cells to boost bone fracture healing. J Clin Invest, 2024. 134(12), e181974.","DOI":"10.1172\/JCI181974"},{"issue":"Supplement 1","key":"1857_CR42","doi-asserted-by":"publisher","first-page":"9755","DOI":"10.1182\/blood-2022-167994","volume":"140","author":"MM Kutyna","year":"2022","unstructured":"Kutyna MM, et al. Senolytic therapy can reverse senescent bone marrow stroma of therapy-related myeloid neoplasm. Blood. 2022;140(Supplement 1):9755\u20136.","journal-title":"Blood"},{"key":"1857_CR43","doi-asserted-by":"publisher","first-page":"111957","DOI":"10.1016\/j.mad.2024.111957","volume":"220","author":"E Bientinesi","year":"2024","unstructured":"Bientinesi E, et al. Quercetin induces senolysis of doxorubicin-induced senescent fibroblasts by reducing autophagy, preventing their pro-tumour effect on osteosarcoma cells. Mech Ageing Dev. 2024;220:111957.","journal-title":"Mech Ageing Dev"},{"issue":"3","key":"1857_CR44","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1007\/s00280-015-2830-8","volume":"76","author":"A Patnaik","year":"2015","unstructured":"Patnaik A, et al. Clinical pharmacology characterization of RG7112, an MDM2 antagonist, in patients with advanced solid tumors. Cancer Chemother Pharmacol. 2015;76(3):587\u201395.","journal-title":"Cancer Chemother Pharmacol"},{"issue":"4","key":"1857_CR45","doi-asserted-by":"publisher","first-page":"433","DOI":"10.3390\/jcm8040433","volume":"8","author":"H Cherif","year":"2019","unstructured":"Cherif H, et al. Curcumin and o-Vanillin Exhibit Evidence of Senolytic Activity in Human IVD Cells In Vitro. J Clin Med. 2019;8(4):433.","journal-title":"J Clin Med"},{"issue":"1","key":"1857_CR46","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/s13075-021-02504-z","volume":"23","author":"M Mannarino","year":"2021","unstructured":"Mannarino M, et al. Toll-like receptor 2 induced senescence in intervertebral disc cells of patients with back pain can be attenuated by o-vanillin. Arthritis Res Ther. 2021;23(1):117.","journal-title":"Arthritis Res Ther"},{"issue":"5","key":"1857_CR47","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1158\/2159-8290.CD-22-1131","volume":"13","author":"CM Adams","year":"2023","unstructured":"Adams CM, et al. Targeted MDM2 Degradation Reveals a New Vulnerability for p53-Inactivated Triple-Negative Breast Cancer. Cancer Discov. 2023;13(5):1210\u201329.","journal-title":"Cancer Discov"},{"issue":"5","key":"1857_CR48","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1111\/febs.16350","volume":"290","author":"L Zhang","year":"2023","unstructured":"Zhang L, et al. Targeting cellular senescence with senotherapeutics: senolytics and senomorphics. FEBS J. 2023;290(5):1362\u201383.","journal-title":"FEBS J"},{"issue":"29","key":"1857_CR49","doi-asserted-by":"publisher","first-page":"11784","DOI":"10.1039\/C9NJ02092F","volume":"43","author":"MR Rodr\u00edguez","year":"2019","unstructured":"Rodr\u00edguez MR, et al. Synthesis, characterization, DFT calculations and anticancer activity of a new oxidovanadium(iv) complex with a ligand derived from o-vanillin and thiophene. New J Chem. 2019;43(29):11784\u201394.","journal-title":"New J Chem"},{"issue":"3","key":"1857_CR50","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1124\/molpharm.121.000354","volume":"101","author":"F Ahmadinejad","year":"2022","unstructured":"Ahmadinejad F, et al. Senolytic-Mediated Elimination of Head and Neck Tumor Cells Induced Into Senescence by Cisplatin. Mol Pharmacol. 2022;101(3):168\u201380.","journal-title":"Mol Pharmacol"},{"issue":"11","key":"1857_CR51","doi-asserted-by":"publisher","first-page":"e113572","DOI":"10.1371\/journal.pone.0113572","volume":"9","author":"Y Li","year":"2014","unstructured":"Li Y, et al. IL-6 Secreted from Senescent Mesenchymal Stem Cells Promotes Proliferation and Migration of Breast Cancer Cells. PLoS ONE. 2014;9(11):e113572.","journal-title":"PLoS ONE"},{"key":"1857_CR52","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adr1719","author":"M Mannarino","year":"2025","unstructured":"Mannarino M, et al. Senolytic treatment for low back pain. Science Advances. 2025. https:\/\/doi.org\/10.1126\/sciadv.adr1719.","journal-title":"Science Advances"},{"key":"1857_CR53","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.00359-18","author":"HH Al-Khalaf","year":"2023","unstructured":"Al-Khalaf HH, et al. Senescent Breast Luminal Cells Promote Carcinogenesis through Interleukin-8-Dependent Activation of Stromal Fibroblasts. Molecular and Cellular Biology. 2023. https:\/\/doi.org\/10.1128\/MCB.00359-18.","journal-title":"Molecular and Cellular Biology"},{"key":"1857_CR54","doi-asserted-by":"publisher","DOI":"10.3390\/cells11091514","author":"L Homann","year":"2022","unstructured":"Homann L, et al. IFN-\u03b3 and TNF Induce Senescence and a Distinct Senescence-Associated Secretory Phenotype in Melanoma. Cells. 2022. https:\/\/doi.org\/10.3390\/cells11091514.","journal-title":"Cells"},{"issue":"6","key":"1857_CR55","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nrc1098","volume":"3","author":"IJ Fidler","year":"2003","unstructured":"Fidler IJ. The pathogenesis of cancer metastasis: the \u2018seed and soil\u2019 hypothesis revisited. Nat Rev Cancer. 2003;3(6):453\u20138.","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"1857_CR56","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.jbo.2012.11.002","volume":"2","author":"Y Zheng","year":"2013","unstructured":"Zheng Y, et al. The role of the bone microenvironment in skeletal metastasis. J Bone Oncol. 2013;2(1):47\u201357.","journal-title":"J Bone Oncol"},{"key":"1857_CR57","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.1063815","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, et al. The RANK\/RANKL\/OPG system and tumor bone metastasis: Potential mechanisms and therapeutic strategies. Frontiers in Endocrinology. 2022. https:\/\/doi.org\/10.3389\/fendo.2022.1063815.","journal-title":"Frontiers in Endocrinology"},{"issue":"11","key":"1857_CR58","doi-asserted-by":"publisher","first-page":"eadr1719","DOI":"10.1126\/sciadv.adr1719","volume":"11","author":"M Mannarino","year":"2025","unstructured":"Mannarino M, et al. Senolytic treatment for low back pain. Sci Adv. 2025;11(11):eadr1719.","journal-title":"Sci Adv"}],"container-title":["Breast Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12282-026-01857-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12282-026-01857-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12282-026-01857-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T15:06:24Z","timestamp":1777388784000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12282-026-01857-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,10]]},"references-count":58,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["1857"],"URL":"https:\/\/doi.org\/10.1007\/s12282-026-01857-0","relation":{},"ISSN":["1340-6868","1880-4233"],"issn-type":[{"value":"1340-6868","type":"print"},{"value":"1880-4233","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,10]]},"assertion":[{"value":"9 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}